Filing Details

Accession Number:
0001021771-23-000088
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-06 17:53:45
Reporting Period:
2023-09-06
Accepted Time:
2023-09-06 17:53:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1505497 Biorestorative Therapies Inc. BRTX Services-Misc Health & Allied Services, Nec (8090) 911835664
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1756228 Lance Alstodt Biorestorative Therapies, Inc.
40 Marcus Drive, Suite 1
Melville NY 11747
President, Ceo, Cob No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-06 2,887 $1.96 187,305 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $5.08 2031-03-18 293,479 293,479 Direct
Common Stock Stock Option $5.08 2031-11-04 42,059 42,059 Direct
Common Stock Stock Option $2.91 2033-02-17 106,762 106,762 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2031-03-18 293,479 293,479 Direct
2031-11-04 42,059 42,059 Direct
2033-02-17 106,762 106,762 Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $1.93 to $2.02 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
  2. Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024.
  3. The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
  4. The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 and 21,029 shares in eight nearly equal quarterly installments beginning November 4, 2022 and continuing every three months thereafter until fully vested.
  5. The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning February 17, 2024 and continuing every three months thereafter until fully vested.